Blood Cancer United Rings Nasdaq Closing Bell
Blood Cancer United marked the end of Blood Cancer Awareness Month by ringing the Nasdaq closing bell in New York. The event celebrated a milestone of nearly 26 million life-years saved due to treatment advances, extending patient survival.
Blood Cancer United, formerly The Leukemia & Lymphoma Society, rang the Nasdaq Stock Market Closing Bell in New York on Monday. The ceremony concluded Blood Cancer Awareness Month and celebrated a significant milestone in extending patient time.
An analysis by Blood Cancer United found that advances in blood cancer treatment have saved nearly 26 million life-years over the past 75 years. This scientific progress has translated into more time for patients and their families.
"Many blood cancers are not curable, but they are increasingly treatable, allowing people to live longer, often relatively normal lives," said Dr. E. Anders Kolb, president and CEO of Blood Cancer United. "For that reason, time is such a meaningful measure of progress. Nearly 26 million life-years represents more birthdays, more graduations, and more moments with the people who matter most."
Dr. Kolb rang the bell alongside survivors, volunteers, donors, and staff. The event recognized collective efforts to advance research, improve access to care, and expand support for those affected by blood cancer. Since its founding in 1949, the organization has focused on supporting blood cancer patients through research, advocacy, and patient services.